AstraZeneca informs European Union of vaccine delivery issues
Expectations Astrazeneca
Over the current book year the company from Cambridge could achieve a revenue around 26.32 billion GBp (consensus estimates). This is slightly more than 2019's revenue of 24.38 billion GBp.
Historical revenues and results Astrazeneca plus estimates 2020
Astrazeneca The analysts expect for 2020 a net profit of 5.3 billion GBp. According to most of the analysts the company will have a profit per share for this book year of 396 GBp. Based on this the price/earnings-ratio is 20.08.
Huge dividend Astrazeneca
Analysts expect a dividend of 281 GBp per share. Astrazeneca 's dividend yield thus equals 3.53 percent. The average dividend yield of the pharmaceutical companies is a moderate 0.16 percent.Recent target prices around 8893 GBp
The most recent recommendations for the pharmaceutical company are from Credit Suisse , Jefferies & Co. and Liberum.Astrazeneca 's market capitalization is based on the number of outstanding shares around 10075.5 billion GBp. The Astrazeneca stock was the past 12 months quite volatile. Since last January the stock is 8 percent higher. This year the stock price moved between 5871 and 10120 GBp.
Historical stock prices Astrazeneca period 2007-2020
Click here for dividend Astrazeneca. On Tuesday the stock closed at 7952 GBp.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
